Mini Review
Published on 24 Feb 2023
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1149616
- 2,399 views
- 6 citations
Type at least 3 characters
2,923 articles
Articles
Review
Published on 23 Feb 2023
Macrophage – tumor cell interaction beyond cytokines
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1078029
- 2,465 views
- 4 citations
Review
Published on 23 Feb 2023
Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1120278
- 4,070 views
- 8 citations
Review
Published on 23 Feb 2023
Pathogen-driven cancers from a structural perspective: Targeting host-pathogen protein-protein interactions
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1061595
- 2,068 views
- 1 citation
Brief Research Report
Published on 23 Feb 2023
LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1142886
- 2,943 views
- 6 citations
Original Research
Published on 22 Feb 2023
Machine learning-based neddylation landscape indicates different prognosis and immune microenvironment in endometrial cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1084523
- 2,279 views
- 10 citations
Original Research
Published on 21 Feb 2023
Primary extra-gastrointestinal stromal tumor of retroperitoneum: Clinicopathologic characteristics and prognosis of six cases
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1033598
- 1,794 views
- 2 citations
Review
Published on 21 Feb 2023
Distinctive modulation of hepcidin in cancer and its therapeutic relevance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1141603
- 2,775 views
- 5 citations
Original Research
Published on 21 Feb 2023
The BAP31/miR-181a-5p/RECK axis promotes angiogenesis in colorectal cancer via fibroblast activation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1056903
- 2,659 views
- 9 citations
Original Research
Published on 21 Feb 2023
Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1058337
- 5,117 views
- 17 citations
Original Research
Published on 20 Feb 2023
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1073793
- 4,362 views
- 1 citation
Review
Published on 20 Feb 2023
Emerging roles of endoplasmic reticulum stress in the cellular plasticity of cancer cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1110881
- 5,444 views
- 9 citations
Editorial
Published on 17 Feb 2023
Editorial: The role of STAT3 signaling pathway in tumor progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1151862
- 2,224 views
- 1 citation
Original Research
Published on 16 Feb 2023
USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1023292
- 3,264 views
- 3 citations
Original Research
Published on 16 Feb 2023
A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.905139
- 3,822 views
- 1 citation
Original Research
Published on 16 Feb 2023
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1129832
- 2,638 views
- 3 citations